Asthma patients are unfamiliar with biologic brands, but open to try — Phreesia survey

People living with asthma are open to trying new biologic treatments now on the market — they just haven’t heard of them. Only 5% have heard of Dupixent, Sanofi and Regeneron’s multi-indication asthma and eczema blockbuster, a new survey from Phreesia reported.

Considering the fact that Dupixent spent more than...

Click to view original post